DART Labs & Ventures

DART Labs & Ventures is a Zurich-based early-stage venture capital firm founded in 2017 by Sophie Lamparter and Arijana Walcott, both serving as Managing Partners, with a satellite office at swissnex San Francisco. The firm invests in European academics, innovators, and early-stage entrepreneurs working on breakthrough technologies for health and climate impact, with a notable 50% diversity factor across its portfolio. DART provides each portfolio company with a tailored 12-month acceleration program designed specifically to help European startups navigate and expand into the US market. DART leads rounds and deploys $200,000 to $300,000 at pre-seed and seed stages. The health portfolio includes Bea Fertility in at-home fertility care, BottNeuro in digital brain health, Impli in implantable bio-sensors, Perivision in AI-powered vision care, Resmonics in remote lung monitoring, Una Health in blood sugar tracking, and Xsensio in on-skin bio-sensors. The climate portfolio spans Fluidsolids in bioplastics, Gaeastar in sustainable cups, Inergio in mini fuel cells, and Orbillion Bio in cultivated meat. Across 15 investments, the firm has recorded 1 exit (VAY, September 2021). A 30-plus-member advisory network spanning Google, Meta, Stanford, ETH Zurich, Daimler, Takeda, and True Ventures provides portfolio companies with access to corporate partners, academic institutions, and top-tier investors. Venture Partner Priska Roesli leads the firm's finance function. DART also operates Vitamin°C, a female-led initiative focused on climate change mitigation.